Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA.
Alfredo AguilarLuis MasDaniel Y Enriquez-VeraCarlos VallejosRosa GutarraClaudio Flores FloresPublished in: Cancer control : journal of the Moffitt Cancer Center (2022)
Progression-Free Survival and OS were superior in patients who received targeted therapy than those treated only with CHT, the 2 years rate of PFS and OS was nearly double to those who received only CHT-based treatments.
Keyphrases